Basit öğe kaydını göster

Effect of maximum-tolerated doses and low-dose metronomic chemotherapy on serum vascular endothelial growth factor and thrombospondin-1 levels in patients with advanced nonsmall cell lung cancer

dc.contributor.authorTopuz, Erkan
dc.contributor.authorTas, Faruk
dc.contributor.authorSoydinc, Hilal O.
dc.contributor.authorSelam, Meltem
dc.contributor.authorYasasever, Vildan
dc.contributor.authorCicin, Irfan
dc.contributor.authorDuranyildiz, Derya
dc.contributor.authorDisci, Rian
dc.contributor.authorUygun, Kazim
dc.date.accessioned2021-03-06T20:29:41Z
dc.date.available2021-03-06T20:29:41Z
dc.date.issued2008
dc.identifier.citationTas F., Duranyildiz D., Soydinc H. O. , Cicin I., Selam M., Uygun K., Disci R., Yasasever V., Topuz E., "Effect of maximum-tolerated doses and low-dose metronomic chemotherapy on serum vascular endothelial growth factor and thrombospondin-1 levels in patients with advanced nonsmall cell lung cancer", CANCER CHEMOTHERAPY AND PHARMACOLOGY, cilt.61, ss.721-725, 2008
dc.identifier.issn0344-5704
dc.identifier.otherav_fa6c75cf-3413-4dfa-ab21-2ecb3f0af607
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/163971
dc.identifier.urihttps://doi.org/10.1007/s00280-007-0526-4
dc.description.abstractBackground Angiogenesis is regulated by a balance of both angiogenic inducers and inhibitors. This study was designed to evaluate the effect of both maximum-tolerated doses (MTD) and low-dose metronomic chemotherapy (LDM) on serum vascular endothelial growth factor (VEGF), thrombospondin-1 (TSP1) and VEGFR1 concentrations in patients with advanced nonsmall cell lung cancer.
dc.language.isoeng
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectOncology
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectPharmacology
dc.subjectGeneral Pharmacology, Toxicology and Pharmaceutics
dc.subjectPharmacology, Toxicology and Pharmaceutics (miscellaneous)
dc.subjectPharmacology (medical)
dc.subjectPharmacy
dc.subjectDrug Guides
dc.titleEffect of maximum-tolerated doses and low-dose metronomic chemotherapy on serum vascular endothelial growth factor and thrombospondin-1 levels in patients with advanced nonsmall cell lung cancer
dc.typeMakale
dc.relation.journalCANCER CHEMOTHERAPY AND PHARMACOLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume61
dc.identifier.issue5
dc.identifier.startpage721
dc.identifier.endpage725
dc.contributor.firstauthorID7332


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster